A detailed history of Boxer Capital, LLC transactions in Merus N.V. stock. As of the latest transaction made, Boxer Capital, LLC holds 1,900,000 shares of MRUS stock, worth $94.4 Million. This represents 5.04% of its overall portfolio holdings.

Number of Shares
1,900,000
Previous 1,900,000 -0.0%
Holding current value
$94.4 Million
Previous $112 Million 15.57%
% of portfolio
5.04%
Previous 6.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

BUY
$16.14 - $29.11 $7.62 Million - $13.7 Million
472,151 Added 33.07%
1,900,000 $39.7 Million
Q4 2020

Feb 16, 2021

BUY
$11.4 - $18.36 $16.3 Million - $26.2 Million
1,427,849 New
1,427,849 $25 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.